Journal of Alzheimer's Disease is devoted to metal ions and neurodegenerative diseasesJanuary 13, 2006Volume 8, Issue 2 The human body contains many metals, from the iron in hemoglobin to the calcium in bones. Other metals, usually in trace amounts, participate in many metabolic and degenerative processes. The recent issue of the Journal of Alzheimer's Disease (Volume 8, Issue 2) published by IOS Press is devoted to "Metal Ions and Neurodegenerative Diseases" and presents a collection of important papers dedicated to uncovering the role of various metals in human neurophysiology and neurodegenerative disorders, particularly Alzheimer's Disease. Guest editor Paolo Zatta, CNR-Institute for Biomedical Technologies, Metalloproteins Unit, Department of Biology, University of Padova, Italy, sets the stage for the special issue. "Metal ions are essential building blocks for life. However, they are also deeply implicated in pathological events related to their depletion or abnormal accumulation in human and animal tissues, mainly the brain, with consequent neurodegenerative phenomena," he writes in the foreword, dedicated to Professor Marino Nicolini. "In the last three decades abundant scientific literature has attributed an important role to metal ions in neurodegenerative disorders such as Alzheimer's (AD), Parkinson's, Huntingtons's, Menkes' and Wilson's diseases, as well as amyotrophic lateral sclerosis, prion diseases and others." The issue contains 11 research and review papers, a conference report from the 3rd International Conference on Metals and the Brain and the transcript of a live discussion among leading researchers in the field. With papers covering iron and aluminum metabolism, zinc biochemistry, calcium and copper disorders, and other metal-related pathologies, this special issue provides key insights into the neurological effects of metals in the human body. Case Western Reserve University |
|||||||||||||||||||||
| Related Neurodegenerative Diseases Current Events and Neurodegenerative Diseases News Articles An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. Cognitive dysfunction reversed in mouse model of Down syndrome A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. Researchers find potential treatment for Huntington's disease Investigators at Burnham Institute for Medical Research (Burnham), the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington's disease. Inhibitor of heat shock protein is a potential anticancer drug, Penn study finds Like yoga for office drones, cells do have coping strategies for stress. Heat, lack of nutrients, oxygen radicals - all can wreak havoc on the delicate internal components of a cell, potentially damaging it beyond repair. Trembling hands and molecular handshakes Fragile X tremor/ataxia syndrome (FXTAS) is a recently recognized condition, which is actually one of the most prevalent heritable neurodegenerative diseases. Neurologists Investigate Possible New Underlying Cause of MS Neurologists at the University at Buffalo are beginning a research study that could overturn the prevailing wisdom on the cause of multiple sclerosis (MS). Scientists remove amyloid plaques from brains of live animals with Alzheimer's disease A breakthrough discovery by scientists from the Mayo Clinic in Jacksonville, FL, may lead to a new treatment for Alzheimer's Disease that actually removes amyloid plaques-considered a hallmark of the disease-from patients' brains. Study supports possible role of urate in slowing Parkinson's disease progression By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases (MGH-MIND) and Harvard School of Public Health (HSPH), has found evidence supporting the findings of their 2008 study - that elevated levels of the antioxidant urate may slow the progression of Parkinson's disease. Amyotrophic lateral sclerosis may involve a form of sudden, rapid aging of the immune system Premature aging of the immune system appears to play a role in the development of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to research scientists from the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, the Weizmann Institute of Science in Israel, and Sheba Medical Center in Israel. Prion study reveals first direct information about the protein's molecular structure A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions. More Neurodegenerative Diseases Current Events and Neurodegenerative Diseases News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||